Improvement of outcomes of an escalated high‐dose methotrexate-based regimen for patients with newly diagnosed primary central nervous system lymphoma: a real-world cohort study

Improvement of outcomes of an escalated high‐dose methotrexate-based regimen for patients with newly diagnosed primary central nervous system lymphoma: a real-world cohort study

Qing Li,1,2,* Jingjing Ma,1,2,* Yan Ma,1,2 Zhiguang Lin,1,2 Hui Kang,1,2 Bobin Chen1,2 1Department of Hematology, Huashan Hospital North, Fudan University, Shanghai, 201907, People’s Republic of China; 2Department of Hematology, Huashan Hospital, Fudan University, Shanghai, 200040, P...

Full description

Bibliographic Details
Main Authors: Li Q, Ma J, Ma Y, Lin Z, Kang H, Chen B
Format: Article
Language:English
Published: Dove Medical Press 2021-08-01
Series:Cancer Management and Research
Subjects:
primary central nervous system lymphoma
high-dose methotrexate
chemotherapy
prognosis
Online Access:https://www.dovepress.com/improvement-of-outcomes-of-an-escalated-highdose-methotrexate-based-re-peer-reviewed-fulltext-article-CMAR

Internet

https://www.dovepress.com/improvement-of-outcomes-of-an-escalated-highdose-methotrexate-based-re-peer-reviewed-fulltext-article-CMAR

Similar Items